AMERISAFE, Inc.
AMERISAFE, Inc. (AMSF) Financial Performance & Income Statement Overview
Analyze AMERISAFE, Inc. (AMSF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
AMERISAFE, Inc. (AMSF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for AMERISAFE, Inc. AMSF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $72.60M | $74.05M | $78.71M | $75.83M |
| Cost of Revenue | $8.28M | -$11.45M | $15.63M | $14.51M |
| Gross Profit | $72.60M | $74.05M | $63.08M | $61.32M |
| Gross Profit Ratio | $1.00 | $1.00 | $0.80 | $0.81 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $8.28M | $9.31M | $7.75M | $7.24M |
| Operating Expenses | -$11.22M | -$16.77M | -$17.79M | -$13.74M |
| Total Costs & Expenses | $61.39M | $43.16M | $7.75M | -$13.74M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $214000.00 | $258000.00 | $277000.00 | $230000.00 |
| EBITDA | $11.44M | $17.03M | $18.07M | $13.97M |
| EBITDA Ratio | $0.16 | $0.23 | $0.23 | $0.18 |
| Operating Income | $11.21M | $16.77M | $17.78M | $13.74M |
| Operating Income Ratio | $0.15 | $0.23 | $0.23 | $0.18 |
| Other Income/Expenses (Net) | $16000.00 | $0.00 | $13000.00 | $16000.00 |
| Income Before Tax | $11.22M | $16.77M | $17.79M | $13.74M |
| Income Before Tax Ratio | $0.15 | $0.23 | $0.23 | $0.18 |
| Income Tax Expense | $2.27M | $3.58M | $3.47M | $2.75M |
| Net Income | $8.95M | $13.19M | $14.32M | $10.99M |
| Net Income Ratio | $0.12 | $0.18 | $0.18 | $0.14 |
| EPS | $0.47 | $0.69 | $0.75 | $0.58 |
| Diluted EPS | $0.47 | $0.69 | $0.75 | $0.57 |
| Weighted Avg Shares Outstanding | $19.04M | $19.07M | $19.04M | $19.08M |
| Weighted Avg Shares Outstanding (Diluted) | $19.15M | $19.12M | $19.11M | $19.15M |
Over the past four quarters, AMERISAFE, Inc. demonstrated steady revenue growth, increasing from $75.83M in Q2 2024 to $72.60M in Q1 2025. Operating income reached $11.21M in Q1 2025, maintaining a consistent 15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $11.44M, reflecting operational efficiency. Net income dropped to $8.95M, with EPS at $0.47. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan